Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 10.40 Revenue Interests Assignment Agreement
- 10.43 Employment Agreement with Mark Glickman Dated August 16, 2007
- 10.44 Amendment to Employment Agreement with Mark Glickman Dated August 22, 2007
- 10.45 Amendment to Employment Agreement with Mark Glickman Dated July 28, 2008
- 12.1 Statement Re: Computation of Ratios
- 23.1 Consent of Ernst & Young LLP
OSCI similar filings
- 7 Nov 08 Registration of securities issued in business combination transactions (amended)
- 21 Oct 08 Registration of securities issued in business combination transactions (amended)
- 8 Oct 08 Registration of securities issued in business combination transactions (amended)
- 10 Sep 08 Registration of securities issued in business combination transactions
- 18 Apr 07 Registration of securities issued in business combination transactions (amended)
- 29 Mar 07 Registration of securities issued in business combination transactions (amended)
- 15 Mar 07 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.1
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 4, 2008, with respect to the consolidated financial statements and schedule of Oscient Pharmaceuticals Corporation included in the Registration Statement (Form S-4) and related Prospectus of Oscient Pharmaceuticals Corporation for the registration of 12.50% Convertible Senior Notes due 2011 and shares of its common stock.
/s/ Ernst & Young LLP
Boston, Massachusetts
September 5, 2008